Stern Named VP for Health Affairs at UC
Stern, who became dean Aug. 1, 2005, will assume additional responsibilities at the UC Academic Health Center currently held by Jane Henney, MD, senior vice president for health affairs and provost. Henney recently announced her decision not to seek an extension of her contract with the university when it expires in June 2008. She will assume a faculty position in the
I am enthusiastic to take up these new duties on behalf of the
Sterns new responsibilities were announced by UC President Nancy Zimpher Dec. 18 in a memo to faculty and staff.
In another organizational change at the
For academic purposes, the deans of Allied Health Sciences, Nursing and Pharmacy will report to Provost Perzigian. For clinical purposes, these same deans will report through Vice President Stern, Zimpher said in her announcement.
I am confident that these changes will strengthen our cross-disciplinary efforts across the entire campus, provide more efficiencies and integration of services in the future, and will strengthen the Academic Health Center and its relationship with UC Physicians, University Hospital and the Health Alliance, Zimpher said. I believe we will be a stronger university and our broader communitys educational and health care needs will be better served by a more integrated university administration.
College of Medicine Dean and Vice President for Health Affairs David Stern, MD
David Stern, MD
Related Stories
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
Phase 1 trial tests probiotic treatment for radiation side effects in the gut
March 9, 2026
The University of Cincinnati Cancer Center’s Bailey Nelson, MD, has been awarded a $50,000 pilot grant from the Cancer Center to open a Phase 1 trial testing if a probiotic supplement can reduce gastrointestinal symptoms for patients undergoing whole pelvis radiotherapy.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.